Association of single nucleotide polymorphic variants of the NOS1AP gene with QT interval duration
https://doi.org/10.17802/2306-1278-2022-11-2-18-26
Abstract
Highlights. The association of single nucleotide polymorphic variants rs12143842 and rs4657139 of the NOS1AP gene with the duration of the QT interval was found in men of the Siberian population.
Aim. To study the association of single nucleotide variants rs12143842 and rs4657139 of the NOS1AP gene with the duration of the QT interval.
Methods. The study sample of men (1353 people) aged 25–69 years was formed from the DNA bank of participants in the international HAPIEE project and screening of young people 25–44 years old, residents of Novosibirsk. From each age subgroup (25–29, 30–34, …, 65–69 years old), about 10–15% of men with the shortest, average and longest QT interval were selected and the corresponding groups were formed. Genotyping of rs4657139 was carried out using PCR with RFLP (polymerase chain reaction followed by restriction fragment length polymorphism analysis). Genotyping rs12143842 – using RT-PCR (real-time polymerase chain reaction).
Results. At the age of over 50 years, the CC genotype rs12143842 was detected in 66.1% of men in the group with a short and average QT interval and in 50.6% in the group with a long QT interval, while the TT genotype prevailed in the group with a long QT interval, 10, 8% of cases (odds ratio (OR) = 3.345, 95% confidence interval (CI) 1.149–9.739, p = 0.02). The homozygous TT genotype rs4657139 was more common in the long QT group, in 20.1% of cases, while the AA and AT genotypes predominated in the short, average QT groups (p = 0.041). A similar trend persists when separating by age in people over 50 years of age (p = 0.031) and when comparing genotype frequencies in the long and average QT groups in the model TT vs AA + AT & long QT vs short + average QT (p = 0.003).
Conclusion. Single nucleotide variants rs12143842 and rs4657139 of the NOS1AP gene are associated with the duration of the QT interval in male residents of Novosibirsk.
About the Authors
A. M. NesteretsRussian Federation
Nesterets Alina M., Postgraduate Student of the Research Institute of Therapy and Preventive Medicine – Branch of the Federal State Budgetary Scientific Institution "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russian Federation; Junior Researcher of the Sector for the Study of Monogenic Forms of Common Human Diseases of the Federal State Budgetary Scientific Institution "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences"
175/1, B. Bogatkova Str., Novosibirsk, 630089;
10, Lavrentyeva Ave., Novosibirsk, 630090
Competing Interests:
А.М. Нестерец заявляет об отсутствии конфликта интересов.
A. A. Kuznetsov
Russian Federation
Kuznetsov Alexander A., MD, Leading Researcher at the Laboratory of Molecular Genetic Studies of Therapeutic Diseases
175/1, B. Bogatkova Str., Novosibirsk, 630089
Competing Interests:
А.А. Кузнецов заявляет об отсутствии конфликта интересов.
A. A. Ivanova
Russian Federation
Ivanova Anastasia A., Candidate of Medical Sciences, Senior Researcher at the Laboratory of Molecular Genetic Studies of Therapeutic Diseases
175/1, B. Bogatkova Str., Novosibirsk, 630089
Competing Interests:
А.А. Иванова заявляет об отсутствии конфликта интересов.
A. A. Gurazheva
Russian Federation
Gurazheva Anna A., Junior Researcher at the Laboratory of Molecular Genetic Studies of Therapeutic Diseases
175/1, B. Bogatkova Str., Novosibirsk, 630089
Competing Interests:
А.А. Гуражева заявляет об отсутствии конфликта интересов.
S. K. Maliutina
Russian Federation
Malyutina Sofya K., MD, Professor, Head of the Laboratory of Etiopathogenesis and Clinic of Internal Diseases
175/1, B. Bogatkova Str., Novosibirsk, 630089
Competing Interests:
С.К. Малютина заявляет об отсутствии конфликта интересов.
D. V. Denisova
Russian Federation
Denisova Diana V., MD, Chief Researcher of the Laboratory of Preventive Medicine
175/1, B. Bogatkova Str., Novosibirsk, 630089
Competing Interests:
Д.В. Денисова заявляет об отсутствии конфликта интересов.
V. N. Maksimov
Russian Federation
Maximov Vladimir N., MD, Professor, Head of the Laboratory of Molecular Genetic Studies of Therapeutic Diseases of the Research Institute of Therapy and Preventive Medicine – Branch of the Federal State Budgetary Scientific Institution "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences", Novosibirsk, Russian Federation; Chief Researcher of the Interinstitutional Sector of Molecular Epidemiology and Human Evolution with the assignment of duties of the Head of the Laboratory of Human Molecular Genetics of the Federal State Budgetary Scientific Institution "Federal Research Center Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences"
175/1, B. Bogatkova Str., Novosibirsk, 630089;
10, Lavrentyeva Ave., Novosibirsk, 630090
Competing Interests:
В.Н. Максимов заявляет об отсутствии конфликта интересов.
References
1. Markwerth P., Bajanowski T., Tzimas I., Dettmeyer R. Sudden cardiac death-update. Int J Legal Med. 2021;135(2):483- 495. doi: 10.1007/s00414-020-02481-z
2. Wong C.X, Brown A., Lau D.H., Chugh S.S., Albert C.M., Kalman J.M., Sanders P. Epidemiology of Sudden Cardiac Death: Global and Regional Perspectives. Heart Lung. Circ. 2019; 28 (1): 6-14. doi: 10.1016/j.hlc.2018.08.026
3. Pigolkin Yu.I., Shylova M.A., Zakharov S.N., Sereda A.P., Zholinskiy A.V., Kruglova I.V., Shigeev S.V. The sudden death among the young persons under effect of the different forms of physical loads. Sudebno-Meditsinskaya Ekspertisa. 2019; 62 (1): 50-55. (In Russian). doi: 10.17116/sudmed20196201150
4. Linchak R.M., Nedbajkin A.M., Semencova E.V., Jusova I.A., Strukova V.V. Frequency and structure of sudden cardiac mortality of the working population of the Bryansk region. Data of the register GERMIN (register of sudden cardiac mortality of the working population of the Bryansk region). Racional’naja farmakoterapija v kardiologii – Rational pharmacotherapy in cardiology. 2016; 12 (1): 45–50. (In Russian)
5. Zaitsev D.N., Vasilenko P.V., Govorin A.V., Vasilenko E.A., Mukha N.V., Filev A.P., Brizhko A.N., Petrova N.G., Sazonova E.A. 2017-2019 Sudden cardiac death registry of the Zabaykalsky Krai population (ZODIAC). Russian Journal of Cardiology. 2020; 25 (11): 3997. (In Russian). doi: 10.15829/29/1560-4071-2020-3997
6. Scrocco C., Bezzina C.R., Ackerman M.J., Behr E.R. Genetics and genomics of arrhythmic risk: current and future strategies to prevent sudden cardiac death. Nature Reviews Cardiology. Nat Rev Cardiol. 2021; 18 (11): 774-784. doi: 10.1038/s41569-021-00555-y
7. Priori S.G., Blomström-Lundqvist C., Mazzanti A., Blom N., Borggrefe M., Camm J., Elliott P.M., Fitzsimons D., Hatala R., Hindricks G., Kirchhof P., Kjeldsen K., Kuck K.H., Hernandez-Madrid A., Nikolaou N., Norekvål T.M., Spaulding C., Van Veldhuisen D.J., Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 2015; 36 (41): 2793-2867. doi: 10.1093/eurheartj/ehv316
8. Crotti L., Monti M.C., Insolia R., Peljto A., Goosen A., Brink P.A., Greenberg D.A., Schwartz P.J., George A.L. Jr. NOS1AP is a genetic modifier of the long-QT syndrome. Circulation. 2009; 120 (17): 1657-1663. doi: 10.1161/CIRCULATIONAHA.109.879643
9. Winbo A., Stattin E.L., Westin I.M., Norberg A., Persson J., Jensen S.M., Rydberg A. Sex is a moderator of the association between NOS1AP sequence variants and QTc in two long QT syndrome founder populations: a pedigree-based measured genotype association analysis. BMC Med Genet. 2017; 18 (1): 74. doi: 10.1186/s12881-017-0435-2
10. Ronchi C., Bernardi J., Mura M., Stefanello M., Badone B., Rocchetti M., Crotti L., Brink P., Schwartz P.J., Gnecchi M., Zaza A. NOS1AP polymorphisms reduce NOS1 activity and interact with prolonged repolarization in arrhythmogenesis. Cardiovasc Res. 2021; 117 (2): 472–483. doi: 10.1093/cvr/cvaa036
11. Tomás M., Napolitano C., De Giuli L., Bloise R., Subirana I., Malovini A., Bellazzi R., Arking D.E., Marban E., Chakravarti A., Spooner P.M., Priori S.G. Polymorphisms in the NOS1AP Gene Modulate QT Interval Duration and Risk of Arrhythmias in the Long QT Syndrome. J Am Coll Cardiol. 2010; 55 (24): 2745–2752. doi: 10.1016/j.jacc.2009.12.065
12. Jamshidi Y., Nolte I.M., Dalageorgou С., Zheng D., Johnson T., Bastiaenen R., Ruddy S., Talbott D., Norris K.P., Snieder H., George A.L., Marshall V., Shakir S., Kannankeril P.J., Munroe P.B., Camm A.J., Jeffery S., Roden D.M., Behr E.R. Common variation in the NOS1AP gene is associated with druginduced QT prolongation and ventricular arrhythmia. J Am Coll Cardiol. 2012; 60 (9): 841–850. doi: 10.1016/j.jacc.2012.03.031
13. 13 Peasey A., Bobak M., Kubinova R., Malyutina S., Pajak A., Tamosiunas A., Pikhart H., Nicholson A., Marmot M. Determinants of cardiovascular disease and other noncommunicable diseases in Central and Eastern Europe: Rationale and design of the HAPIEE study. BMC Public Health. 2006; 6: 255. doi: 10.1186/1471-2458-6-255.
14. Ragino Yu.I., Kuzminykh N.A., Shcherbakova L.V., Denisova D.V., Shramko V.S., Voevoda M.I. Prevalence of coronary heart disease (by epidemiological criteria) and its association with lipid and non-lipid risk factors in the Novosibirsk population of 25-45 years. Russian Journal of Cardiology. 2019; (6): 78-84. doi: 10.15829/1560-4071-2019-6-78-84.
15. Aarnoudse A.J., Newton-Cheh C., de Bakker P.I., Straus S.M., Kors J.A., Hofman A., Uitterlinden A.G., Witteman J.C., Stricker B.H. Common NOS1AP variants are associated with a prolonged QTc interval in the Rotterdam Study. Circulation. 2007; 116 (1): 10-16. doi: 10.1161/CIRCULATIONAHA.106.676783
16. Lahrouchi N., Tadros R., Crotti L., Mizusawa Y., Postema P.G., Beekman L., Walsh R., Hasegawa K., Barc J., Ernsting M. et al. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome. Circulation. 2020; 142 (4): 324-338. doi: 10.1161/CIRCULATIONAHA.120.045956
17. Arking D.E., Pulit S.L., Crotti L., van der Harst P., Munroe P.B., Koopmann T.T., Sotoodehnia N., Rossin E.J., Morley M. et al. Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization. Nat Genet. 2014; 46 (8): 826–836. doi: 10.1038/ng.3014
18. Mitchell R.N., Ashar F.N., Jarvelin M.R., Froguel P., Sotoodehnia N., Brody J.A., Sebert S., Huikuri H., Rioux J., Goyette P., Newcomb C.E., Junttila M.J., Arking D.E. Effect of Sex and Underlying Disease on the Genetic Association of QT Interval and Sudden Cardiac Death. J Am Heart Assoc. 2019; 8 (23): e013751. doi: 10.1161/JAHA.119.013751
19. Orlov P.S., Ivanoshchuk D.Е., Ivanova А.А., Malyutina S.К., Novosyolov V.P., Voevoda М.I., Maximov V.N. Association of polymorphisms KCNN2 and NOS1AP with sudden cardiac death. Russian Journal of Cardiology. 2018; (10): 59-63. (In Russ). doi: 10.15829/1560-4071-2018-10-59-63
20. Porthan K., Marjamaa A., Viitasalo M., Väänänen H., Jula A., Toivonen L., Nieminen M.S., Newton-Cheh C., Salomaa V., Kontula K., Oikarinen L.. Relationship of common candidate gene variants to electrocardiographic T-wave peak to T-wave end interval and T-wave morphology parameters. Heart Rhythm. 2010; 7 (7): 898-903. doi: 10.1016/j.hrthm.2010.03.002
Review
For citations:
Nesterets A.M., Kuznetsov A.A., Ivanova A.A., Gurazheva A.A., Maliutina S.K., Denisova D.V., Maksimov V.N. Association of single nucleotide polymorphic variants of the NOS1AP gene with QT interval duration. Complex Issues of Cardiovascular Diseases. 2022;11(2):18-26. (In Russ.) https://doi.org/10.17802/2306-1278-2022-11-2-18-26